Not Yet RecruitingNot Applicable

Tunisian Clinical Registry on Hypoparathyroidism and Pseudo-hypoparathyroidism

Tunisia1,000 participantsStarted 2025-02-27

Plain-language summary

Observational, multicenter, national, cross-sectional study aiming to describe the epidemiological clinical, biological and therapeutic profile of patients suffering from defect in secretion (hypoparathyroidism) or action (pseudo-hypoparathyroidism) of parathyroid hormone.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Hypoparathyroidism defined by low serum calcium \< 2.2 mmol/l (\< 88 mg/l) associated with inadequate PTH (low or normal) and normal creatinine Exclusion Criteria: * Cervical surgery \< 6 months. * Transient (neonatal, etc.) or functional (dysmagnesemia, etc.) hypoparathyroidism. * Other causes of hypocalcemia: vitamin D deficiency, chronic renal failure, etc. * Familial hypocalcemia hypercalciuria. * Pseudo-pseudo-hypoparathyroidism.

What they're measuring

Incidence of primary hypoparathyroidism

Timeframe: Day 1

Incidence of congenital hypoparathyroidism

Timeframe: Day 1

Incidence of acquired hypoparathyroidism

Timeframe: Day 1

Incidence of secondary hypoparathyroidism

Timeframe: Day 1

Trial details

NCT IDNCT06445036

SponsorDacima Consulting

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-07-27

Contact for this trial

Nabila Rekik Mejdoub, MD

+216 98 609 300 nabila.rekik.mejdoub@gmail.com

View on ClinicalTrials.gov More Hypoparathyroidism trials